Variability in the Glycosylation Patterns of gp120 Proteins from Different Human Immunodeficiency Virus Type 1 Isolates Expressed in Different Host Cells.


Journal

Journal of proteome research
ISSN: 1535-3907
Titre abrégé: J Proteome Res
Pays: United States
ID NLM: 101128775

Informations de publication

Date de publication:
01 10 2021
Historique:
pubmed: 28 8 2021
medline: 4 11 2021
entrez: 27 8 2021
Statut: ppublish

Résumé

The mature HIV-1 envelope (Env) glycoprotein is composed of gp120, the exterior subunit, and gp41, the transmembrane subunit assembled as trimer by noncovalent interaction. There is a great body of literature to prove that gp120 binds to CD4 first, then to the coreceptor. Binding experiments and functional assays have demonstrated that CD4 binding induces conformational changes in gp120 that enable or enhance its interaction with a coreceptor. Previous studies provided different glycomic maps for the HIV-1 gp120. Here, we build on previous work to report that the use of LC-MS/MS, in conjunction with hydrophilic interaction liquid chromatography (HILIC) enrichment to glycosylation sites, associated with the assorted neutralizing or binding events of glycosylation targeted antibodies from different clades or strains. In this study, the microheterogeneity of the glycosylation from 4 different clades of gp120s is deeply investigated. Aberrant glycosylation patterns were detected on gp120 that originated from different clades, viral sequences, and host cells. The results of this study may help provide a better understanding of the mechanism of how the glycans participate in the antibody neutralizing process that targets glycosylation sites.

Identifiants

pubmed: 34448591
doi: 10.1021/acs.jproteome.1c00587
doi:

Substances chimiques

Antibodies, Neutralizing 0
HIV Envelope Protein gp120 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4862-4874

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM112490
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM130091
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA225753
Pays : United States

Auteurs

Jingfu Zhao (J)

Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, United States.

Ehwang Song (E)

Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, United States.

Yifan Huang (Y)

Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, United States.

Aiying Yu (A)

Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, United States.

Yehia Mechref (Y)

Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH